Originally Published in Corporate Counsel | January 25, 2017 | By Sue Reisinger
Intellectual property lawyers do more than just defend patents and copyrights. Some 75 percent of in-house IP counsel in a recent life sciences survey say they are also involved in company efforts on mergers and acquisitions.
“These executives are increasingly expected to serve as strategic partners to the business—identifying opportunities and leveraging available resources to extract more value from the IP portfolio,” the report explains.
The respondents say their top focus for 2017 includes global IP strategy as well as research and development.
The survey was developed by the Consero Group, which provides forums for executives and in-house counsel, in partnership with the IP law firm Sterne, Kessler, Goldstein & Fox. Some 57 respondents, who included heads of IP from corporations involved with medical devices, pharmaceuticals and biotechnology in the United States and Europe, participated.
See full article here.